Other Consolidated Financial Statement Detail (Tables)

12 Months Ended

Dec. 31, 2014

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Supplementary cash flow information

	For the Years Ended December 31,
(In millions)	2014		2013		2012
Cash paid during the year for:
Interest	$	41.2	$	53.6	$	65.4
Income taxes	$	1,163.2	$	643.2	$	526.6

Other income (expense), net

	For the Years Ended December 31,
(In millions)	2014			2013			2012
Interest income	$	12.2		$	8.2		$	29.5
Interest expense	(29.5		)	(31.9		)	(36.5		)
Impairments on investments	—			(2.8		)	(5.5		)
Gain (loss) on investments, net	11.8			21.7			10.6
Foreign exchange gains (losses), net	(11.6		)	(15.2		)	(2.5		)
Other, net	(8.7		)	(14.9		)	3.7
Total other income (expense), net	$	(25.8	)	$	(34.9	)	$	(0.7	)

Accrued expenses and other

	As of December 31,
(In millions)	2014		2013
Employee compensation and benefits	$	393.8	$	343.4
Revenue-related rebates	344.0		264.9
Current portion of contingent consideration obligations	265.5		54.0
Royalties and licensing fees	172.4		160.7
Deferred revenue	120.9		172.7
Clinical development expenses	65.9		55.2
Other	456.8		304.3
Total accrued expenses and other	$	1,819.3	$	1,355.2

Other long-term liabilities

	As of December 31,
(In millions)	2014		2013
Employee compensation and benefits	$	200.7	$	161.5
Contingent consideration obligation	200.0		251.9
Taxes payable	142.2		177.1
Other	107.2		68.7
Total other long-term liabilities	$	650.1	$	659.2